Literature DB >> 10807194

Evidence that anoreceptive intercourse with ejaculate exposure is associated with rapid CD4 cell loss.

D J Wiley1, B R Visscher, S Grosser, D R Hoover, R Day, S Gange, J S Chmiel, R Mitsuyasu, R Detels.   

Abstract

OBJECTIVE: To determine whether ejaculate exposure through anoreceptive intercourse is associated with rapid CD4 cell loss.
DESIGN: Self-reported behavioral, demographic data and blood samples were gathered longitudinally at ten semiannual visits from individuals participating in the Multicenter AIDS Cohort Study (MACS). PATIENTS/PARTICIPANTS: A group of 937 HIV-seropositive men who were continuously followed for four to ten semiannual visits. OUTCOME MEASURES: A loss of 10% or more in CD4 cells between the first two of any three consecutive semiannual visits that was followed by a 10% or greater loss between the second and third visits.
RESULTS: A period of rapid CD4 cell loss over three semiannual visits occurred in 389 of the 937 (42%) HIV-seropositive men studied. Men who reported one or more anoreceptive intercourse partners with whom they were exposed to ejaculate (RAI-E) during the 12 months immediately preceding their visits were more than twice as likely to show this rapid CD4 cell loss compared with men with no such partners.
CONCLUSIONS: The association between RAI-E partnerships and rapid CD4 cell loss suggests factors associated with ejaculate exposure (e.g., sexually transmitted diseases) may hasten the clinical progression of HIV disease. It is suggested that infectious diseases, which are known to be associated with ejaculate exposure, may be the causal factor underlying the association between RAI-E partnerships and rapid CD4 cell loss in these men, although the presence of these diseases was not ascertained in these data. HIV-infected individuals should be cautioned against unprotected anoreceptive intercourse.

Entities:  

Mesh:

Year:  2000        PMID: 10807194     DOI: 10.1097/00002030-200004140-00010

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

1.  Characteristics of high-risk HIV-positive IDUs in Vietnam: implications for future interventions.

Authors:  Vivian F Go; Constantine Frangakis; Le Van Nam; Teerada Sripaipan; Anna Bergenstrom; Fan Li; Carl Latkin; David D Celentano; Vu Minh Quan
Journal:  Subst Use Misuse       Date:  2010-08-24       Impact factor: 2.164

Review 2.  A strategy for selecting sexual partners believed to pose little/no risks for HIV: serosorting and its implications for HIV transmission.

Authors:  Lisa A Eaton; Seth C Kalichman; Daniel A O'Connell; William D Karchner
Journal:  AIDS Care       Date:  2009-10

3.  Correlates of Never Testing for HIV Among Sexually Active Internet-Recruited Gay, Bisexual, and Other Men Who Have Sex with Men in the United States.

Authors:  Kimberly M Nelson; David W Pantalone; Kristi E Gamarel; Michael P Carey; Jane M Simoni
Journal:  AIDS Patient Care STDS       Date:  2017-12-12       Impact factor: 5.078

4.  HIV transmission risk among HIV seroconcordant and serodiscordant couples: dyadic processes of partner selection.

Authors:  Lisa A Eaton; Tessa V West; David A Kenny; Seth C Kalichman
Journal:  AIDS Behav       Date:  2008-10-25

5.  Prospective predictors of unprotected anal intercourse among HIV-seropositive men who have sex with men initiating antiretroviral therapy.

Authors:  David W Pantalone; David Huh; Kimberly M Nelson; Cynthia R Pearson; Jane M Simoni
Journal:  AIDS Behav       Date:  2014-01

6.  Personal and contextual factors related to delayed HIV diagnosis among men who have sex with men.

Authors:  Kimberly M Nelson; Hanne Thiede; Richard A Jenkins; James W Carey; Rebecca Hutcheson; Matthew R Golden
Journal:  AIDS Educ Prev       Date:  2014-04

7.  Smoking enhances risk for new external genital warts in men.

Authors:  Dorothy J Wiley; David Elashoff; Emmanuel V Masongsong; Diane M Harper; Karen H Gylys; Michael J Silverberg; Robert L Cook; Lisette M Johnson-Hill
Journal:  Int J Environ Res Public Health       Date:  2009-03-20       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.